APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Needle-free Injection Pen

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Insulin Needle-free Injection Pen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

8 January 2026193 pages

Choose your research edition.

Industry ResearchInsulin Needle-free Injection Pen Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Needle-free Injection Pen Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Insulin Needle-free Injection Pen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Needle-free Injection Pen Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Needle-free Injection Pen Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Insulin Needle-free Injection Pen market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Insulin Needle-free Injection Pen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Insulin Needle-free Injection Pen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Needle-free Injection Pen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Insulin Needle-free Injection Pen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Needle-free Injection Pen include Portal Instruments, Injex Pharma, JSK Biomed, Glide Pharma, Antares Pharma, Inc., InsuJet, Miracle Medical, Crossject SA and PharmaJet, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Insulin Needle-free Injection Pen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Insulin Needle-free Injection Pen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insulin Needle-free Injection Pen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin Needle-free Injection Pen market size, projected growth trends, production technologies, key applications, and end-use industries.

Insulin Needle-free Injection Pen Segment by Company

Portal Instruments

Injex Pharma

JSK Biomed

Glide Pharma

Antares Pharma, Inc.

InsuJet

Miracle Medical

Crossject SA

PharmaJet

Mika Medical

Lepu Medical Technology (Beijing) Co., Ltd.

Shandong Zhongbaokang Medical Equipment Co.,Ltd

Jiangxi Sanxin Medtec Co.,Ltd.

Quinovare

Joyomed Suzhou Co.,Ltd.

Sinocare

Insulin Needle-free Injection Pen Segment by Type

Mechanical Force

Electric Force

Optical Force

Insulin Needle-free Injection Pen Segment by Application

Hospital & Clinic

Retail Pharmacies

Online Channel

Insulin Needle-free Injection Pen Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Needle-free Injection Pen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Needle-free Injection Pen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Needle-free Injection Pen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin Needle-free Injection Pen market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Needle-free Injection Pen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Insulin Needle-free Injection Pen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Insulin Needle-free Injection Pen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Insulin Needle-free Injection Pen Industry Trends Table 2. Insulin Needle-free Injection Pen Industry Drivers Table 3. Insulin Needle-free Injection Pen Industry Opportunities and Challenges Table 4. Insulin Needle-free Injection Pen Industry Restraints Table 5. Global Insulin Needle-free Injection Pen Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Insulin Needle-free Injection Pen Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Insulin Needle-free Injection Pen Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Insulin Needle-free Injection Pen Sales Market Share by Manufacturers Table 9. Global Insulin Needle-free Injection Pen Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Insulin Needle-free Injection Pen Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Insulin Needle-free Injection Pen Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Insulin Needle-free Injection Pen Manufacturers, Product Type & Application Table 13. Global Insulin Needle-free Injection Pen Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Insulin Needle-free Injection Pen by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Mechanical Force Table 17. Major Manufacturers of Electric Force Table 18. Major Manufacturers of Optical Force Table 19. Global Insulin Needle-free Injection Pen Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Insulin Needle-free Injection Pen Sales by Type (2021-2026) & (k units) Table 21. Global Insulin Needle-free Injection Pen Sales by Type (2027-2032) & (k units) Table 22. Global Insulin Needle-free Injection Pen Sales Market Share by Type (2021-2026) Table 23. Global Insulin Needle-free Injection Pen Sales Market Share by Type (2027-2032) Table 24. Global Insulin Needle-free Injection Pen Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Insulin Needle-free Injection Pen Revenue by Type (2021-2026) & (k units) Table 26. Global Insulin Needle-free Injection Pen Revenue by Type (2027-2032) & (k units) Table 27. Global Insulin Needle-free Injection Pen Revenue Market Share by Type (2021-2026) Table 28. Global Insulin Needle-free Injection Pen Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital & Clinic Table 30. Major Manufacturers of Retail Pharmacies Table 31. Major Manufacturers of Online Channel Table 32. Global Insulin Needle-free Injection Pen Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Insulin Needle-free Injection Pen Sales by Application (2021-2026) & (k units) Table 34. Global Insulin Needle-free Injection Pen Sales by Application (2027-2032) & (k units) Table 35. Global Insulin Needle-free Injection Pen Sales Market Share by Application (2021-2026) Table 36. Global Insulin Needle-free Injection Pen Sales Market Share by Application (2027-2032) Table 37. Global Insulin Needle-free Injection Pen Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Insulin Needle-free Injection Pen Revenue by Application (2021-2026) & (k units) Table 39. Global Insulin Needle-free Injection Pen Revenue by Application (2027-2032) & (k units) Table 40. Global Insulin Needle-free Injection Pen Revenue Market Share by Application (2021-2026) Table 41. Global Insulin Needle-free Injection Pen Revenue Market Share by Application (2027-2032) Table 42. Global Insulin Needle-free Injection Pen Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Insulin Needle-free Injection Pen Sales by Region (2021-2026) & (k units) Table 44. Global Insulin Needle-free Injection Pen Sales Market Share by Region (2021-2026) Table 45. Global Insulin Needle-free Injection Pen Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Insulin Needle-free Injection Pen Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Insulin Needle-free Injection Pen Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Insulin Needle-free Injection Pen Sales by Country (2021-2026) & (k units) Table 49. North America Insulin Needle-free Injection Pen Sales by Country (2027-2032) & (k units) Table 50. Europe Insulin Needle-free Injection Pen Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Insulin Needle-free Injection Pen Sales by Country (2021-2026) & (k units) Table 52. Europe Insulin Needle-free Injection Pen Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Insulin Needle-free Injection Pen Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Insulin Needle-free Injection Pen Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Insulin Needle-free Injection Pen Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Insulin Needle-free Injection Pen Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Insulin Needle-free Injection Pen Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Insulin Needle-free Injection Pen Sales by Country (2027-2032) & (k units) Table 59. Global Insulin Needle-free Injection Pen Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Insulin Needle-free Injection Pen Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Insulin Needle-free Injection Pen Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Insulin Needle-free Injection Pen Revenue Market Share by Region (2021-2026) Table 63. Global Insulin Needle-free Injection Pen Revenue Market Share by Region (2027-2032) Table 64. Portal Instruments Company Information Table 65. Portal Instruments Business Overview Table 66. Portal Instruments Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Portal Instruments Insulin Needle-free Injection Pen Product Portfolio Table 68. Portal Instruments Recent Development Table 69. Injex Pharma Company Information Table 70. Injex Pharma Business Overview Table 71. Injex Pharma Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Injex Pharma Insulin Needle-free Injection Pen Product Portfolio Table 73. Injex Pharma Recent Development Table 74. JSK Biomed Company Information Table 75. JSK Biomed Business Overview Table 76. JSK Biomed Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. JSK Biomed Insulin Needle-free Injection Pen Product Portfolio Table 78. JSK Biomed Recent Development Table 79. Glide Pharma Company Information Table 80. Glide Pharma Business Overview Table 81. Glide Pharma Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Glide Pharma Insulin Needle-free Injection Pen Product Portfolio Table 83. Glide Pharma Recent Development Table 84. Antares Pharma, Inc. Company Information Table 85. Antares Pharma, Inc. Business Overview Table 86. Antares Pharma, Inc. Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Antares Pharma, Inc. Insulin Needle-free Injection Pen Product Portfolio Table 88. Antares Pharma, Inc. Recent Development Table 89. InsuJet Company Information Table 90. InsuJet Business Overview Table 91. InsuJet Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. InsuJet Insulin Needle-free Injection Pen Product Portfolio Table 93. InsuJet Recent Development Table 94. Miracle Medical Company Information Table 95. Miracle Medical Business Overview Table 96. Miracle Medical Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Miracle Medical Insulin Needle-free Injection Pen Product Portfolio Table 98. Miracle Medical Recent Development Table 99. Crossject SA Company Information Table 100. Crossject SA Business Overview Table 101. Crossject SA Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Crossject SA Insulin Needle-free Injection Pen Product Portfolio Table 103. Crossject SA Recent Development Table 104. PharmaJet Company Information Table 105. PharmaJet Business Overview Table 106. PharmaJet Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. PharmaJet Insulin Needle-free Injection Pen Product Portfolio Table 108. PharmaJet Recent Development Table 109. Mika Medical Company Information Table 110. Mika Medical Business Overview Table 111. Mika Medical Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Mika Medical Insulin Needle-free Injection Pen Product Portfolio Table 113. Mika Medical Recent Development Table 114. Lepu Medical Technology (Beijing) Co., Ltd. Company Information Table 115. Lepu Medical Technology (Beijing) Co., Ltd. Business Overview Table 116. Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Product Portfolio Table 118. Lepu Medical Technology (Beijing) Co., Ltd. Recent Development Table 119. Shandong Zhongbaokang Medical Equipment Co.,Ltd Company Information Table 120. Shandong Zhongbaokang Medical Equipment Co.,Ltd Business Overview Table 121. Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Product Portfolio Table 123. Shandong Zhongbaokang Medical Equipment Co.,Ltd Recent Development Table 124. Jiangxi Sanxin Medtec Co.,Ltd. Company Information Table 125. Jiangxi Sanxin Medtec Co.,Ltd. Business Overview Table 126. Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio Table 128. Jiangxi Sanxin Medtec Co.,Ltd. Recent Development Table 129. Quinovare Company Information Table 130. Quinovare Business Overview Table 131. Quinovare Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Quinovare Insulin Needle-free Injection Pen Product Portfolio Table 133. Quinovare Recent Development Table 134. Joyomed Suzhou Co.,Ltd. Company Information Table 135. Joyomed Suzhou Co.,Ltd. Business Overview Table 136. Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio Table 138. Joyomed Suzhou Co.,Ltd. Recent Development Table 139. Sinocare Company Information Table 140. Sinocare Business Overview Table 141. Sinocare Insulin Needle-free Injection Pen Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Sinocare Insulin Needle-free Injection Pen Product Portfolio Table 143. Sinocare Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Insulin Needle-free Injection Pen Distributors List Table 147. Insulin Needle-free Injection Pen Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Insulin Needle-free Injection Pen Product Image Figure 2. Global Insulin Needle-free Injection Pen Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Needle-free Injection Pen Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Needle-free Injection Pen Sales (2021-2032) & (k units) Figure 5. Global Insulin Needle-free Injection Pen Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Insulin Needle-free Injection Pen Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Mechanical Force Image Figure 9. Electric Force Image Figure 10. Optical Force Image Figure 11. Global Insulin Needle-free Injection Pen Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Insulin Needle-free Injection Pen Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Insulin Needle-free Injection Pen Sales Market Share by Type (2021-2032) Figure 14. Global Insulin Needle-free Injection Pen Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Insulin Needle-free Injection Pen Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Insulin Needle-free Injection Pen Revenue Market Share by Type (2021-2032) Figure 17. Hospital & Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Online Channel Image Figure 20. Global Insulin Needle-free Injection Pen Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Insulin Needle-free Injection Pen Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Insulin Needle-free Injection Pen Sales Market Share by Application (2021-2032) Figure 23. Global Insulin Needle-free Injection Pen Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Insulin Needle-free Injection Pen Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Insulin Needle-free Injection Pen Revenue Market Share by Application (2021-2032) Figure 26. North America Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Insulin Needle-free Injection Pen Sales Market Share by Country (2021-2032) Figure 28. U.S. Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Insulin Needle-free Injection Pen Sales Market Share by Country (2021-2032) Figure 33. Germany Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Insulin Needle-free Injection Pen Sales Market Share by Country (2021-2032) Figure 40. China Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Insulin Needle-free Injection Pen Sales Market Share by Country (2021-2032) Figure 48. Brazil Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Insulin Needle-free Injection Pen Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Insulin Needle-free Injection Pen Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Insulin Needle-free Injection Pen Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Insulin Needle-free Injection Pen Revenue (2021-2032) & (US$ Million) Figure 59. North America Insulin Needle-free Injection Pen Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Insulin Needle-free Injection Pen Revenue (2021-2032) & (US$ Million) Figure 61. Europe Insulin Needle-free Injection Pen Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Insulin Needle-free Injection Pen Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Insulin Needle-free Injection Pen Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Insulin Needle-free Injection Pen Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Insulin Needle-free Injection Pen Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Insulin Needle-free Injection Pen Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Insulin Needle-free Injection Pen Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Mechanical Force
  • Electric Force
  • Optical Force
Applications
  • Hospital & Clinic
  • Retail Pharmacies
  • Online Channel
Companies covered
  • Portal Instruments
  • Injex Pharma
  • JSK Biomed
  • Glide Pharma
  • Antares Pharma, Inc.
  • InsuJet
  • Miracle Medical
  • Crossject SA
  • PharmaJet
  • Mika Medical
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Shandong Zhongbaokang Medical Equipment Co.,Ltd
  • Jiangxi Sanxin Medtec Co.,Ltd.
  • Quinovare
  • Joyomed Suzhou Co.,Ltd.
  • Sinocare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Insulin Needle-free Injection Pen Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Insulin Needle-free Injection Pen Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Insulin Needle-free Injection Pen Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Insulin Needle-free Injection Pen Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Insulin Needle-free Injection Pen Market Dynamics
  1. 2.1 Insulin Needle-free Injection Pen Industry Trends
  2. 2.2 Insulin Needle-free Injection Pen Industry Drivers
  3. 2.3 Insulin Needle-free Injection Pen Industry Opportunities and Challenges
  4. 2.4 Insulin Needle-free Injection Pen Industry Restraints
3 Insulin Needle-free Injection Pen Market by Manufacturers
  1. 3.1 Global Insulin Needle-free Injection Pen Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Insulin Needle-free Injection Pen Sales by Manufacturers (2021-2026)
  3. 3.3 Global Insulin Needle-free Injection Pen Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Insulin Needle-free Injection Pen Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Needle-free Injection Pen Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Insulin Needle-free Injection Pen Manufacturers, Product Type & Application
  7. 3.7 Global Insulin Needle-free Injection Pen Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Needle-free Injection Pen Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Needle-free Injection Pen Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Needle-free Injection Pen Tier 1, Tier 2, and Tier 3
4 Insulin Needle-free Injection Pen Market by Type
  1. 4.1 Insulin Needle-free Injection Pen Type Introduction
  2. 4.1.1 Mechanical Force
  3. 4.1.2 Electric Force
  4. 4.1.3 Optical Force
  5. 4.2 Global Insulin Needle-free Injection Pen Sales by Type
  6. 4.2.1 Global Insulin Needle-free Injection Pen Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Insulin Needle-free Injection Pen Sales by Type (2021-2032)
  8. 4.2.3 Global Insulin Needle-free Injection Pen Sales Market Share by Type (2021-2032)
  9. 4.3 Global Insulin Needle-free Injection Pen Revenue by Type
  10. 4.3.1 Global Insulin Needle-free Injection Pen Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Insulin Needle-free Injection Pen Revenue by Type (2021-2032)
  12. 4.3.3 Global Insulin Needle-free Injection Pen Revenue Market Share by Type (2021-2032)
5 Insulin Needle-free Injection Pen Market by Application
  1. 5.1 Insulin Needle-free Injection Pen Application Introduction
  2. 5.1.1 Hospital & Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Online Channel
  5. 5.2 Global Insulin Needle-free Injection Pen Sales by Application
  6. 5.2.1 Global Insulin Needle-free Injection Pen Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin Needle-free Injection Pen Sales by Application (2021-2032)
  8. 5.2.3 Global Insulin Needle-free Injection Pen Sales Market Share by Application (2021-2032)
  9. 5.3 Global Insulin Needle-free Injection Pen Revenue by Application
  10. 5.3.1 Global Insulin Needle-free Injection Pen Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Insulin Needle-free Injection Pen Revenue by Application (2021-2032)
  12. 5.3.3 Global Insulin Needle-free Injection Pen Revenue Market Share by Application (2021-2032)
6 Global Insulin Needle-free Injection Pen Sales by Region
  1. 6.1 Global Insulin Needle-free Injection Pen Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insulin Needle-free Injection Pen Sales by Region (2021-2032)
  3. 6.2.1 Global Insulin Needle-free Injection Pen Sales by Region (2021-2026)
  4. 6.2.2 Global Insulin Needle-free Injection Pen Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Insulin Needle-free Injection Pen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Insulin Needle-free Injection Pen Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Insulin Needle-free Injection Pen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Insulin Needle-free Injection Pen Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Insulin Needle-free Injection Pen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Insulin Needle-free Injection Pen Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Insulin Needle-free Injection Pen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Insulin Needle-free Injection Pen Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Insulin Needle-free Injection Pen Revenue by Region
  1. 7.1 Global Insulin Needle-free Injection Pen Revenue by Region
  2. 7.1.1 Global Insulin Needle-free Injection Pen Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Insulin Needle-free Injection Pen Revenue by Region (2021-2026)
  4. 7.1.3 Global Insulin Needle-free Injection Pen Revenue by Region (2027-2032)
  5. 7.1.4 Global Insulin Needle-free Injection Pen Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Insulin Needle-free Injection Pen Revenue (2021-2032)
  8. 7.2.2 North America Insulin Needle-free Injection Pen Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Insulin Needle-free Injection Pen Revenue (2021-2032)
  11. 7.3.2 Europe Insulin Needle-free Injection Pen Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Insulin Needle-free Injection Pen Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Insulin Needle-free Injection Pen Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Insulin Needle-free Injection Pen Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Insulin Needle-free Injection Pen Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Portal Instruments
  2. 8.1.1 Portal Instruments Company Information
  3. 8.1.2 Portal Instruments Business Overview
  4. 8.1.3 Portal Instruments Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Portal Instruments Insulin Needle-free Injection Pen Product Portfolio
  6. 8.1.5 Portal Instruments Recent Developments
  7. 8.2 Injex Pharma
  8. 8.2.1 Injex Pharma Company Information
  9. 8.2.2 Injex Pharma Business Overview
  10. 8.2.3 Injex Pharma Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Injex Pharma Insulin Needle-free Injection Pen Product Portfolio
  12. 8.2.5 Injex Pharma Recent Developments
  13. 8.3 JSK Biomed
  14. 8.3.1 JSK Biomed Company Information
  15. 8.3.2 JSK Biomed Business Overview
  16. 8.3.3 JSK Biomed Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 JSK Biomed Insulin Needle-free Injection Pen Product Portfolio
  18. 8.3.5 JSK Biomed Recent Developments
  19. 8.4 Glide Pharma
  20. 8.4.1 Glide Pharma Company Information
  21. 8.4.2 Glide Pharma Business Overview
  22. 8.4.3 Glide Pharma Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glide Pharma Insulin Needle-free Injection Pen Product Portfolio
  24. 8.4.5 Glide Pharma Recent Developments
  25. 8.5 Antares Pharma, Inc.
  26. 8.5.1 Antares Pharma, Inc. Company Information
  27. 8.5.2 Antares Pharma, Inc. Business Overview
  28. 8.5.3 Antares Pharma, Inc. Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Antares Pharma, Inc. Insulin Needle-free Injection Pen Product Portfolio
  30. 8.5.5 Antares Pharma, Inc. Recent Developments
  31. 8.6 InsuJet
  32. 8.6.1 InsuJet Company Information
  33. 8.6.2 InsuJet Business Overview
  34. 8.6.3 InsuJet Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 InsuJet Insulin Needle-free Injection Pen Product Portfolio
  36. 8.6.5 InsuJet Recent Developments
  37. 8.7 Miracle Medical
  38. 8.7.1 Miracle Medical Company Information
  39. 8.7.2 Miracle Medical Business Overview
  40. 8.7.3 Miracle Medical Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Miracle Medical Insulin Needle-free Injection Pen Product Portfolio
  42. 8.7.5 Miracle Medical Recent Developments
  43. 8.8 Crossject SA
  44. 8.8.1 Crossject SA Company Information
  45. 8.8.2 Crossject SA Business Overview
  46. 8.8.3 Crossject SA Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Crossject SA Insulin Needle-free Injection Pen Product Portfolio
  48. 8.8.5 Crossject SA Recent Developments
  49. 8.9 PharmaJet
  50. 8.9.1 PharmaJet Company Information
  51. 8.9.2 PharmaJet Business Overview
  52. 8.9.3 PharmaJet Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PharmaJet Insulin Needle-free Injection Pen Product Portfolio
  54. 8.9.5 PharmaJet Recent Developments
  55. 8.10 Mika Medical
  56. 8.10.1 Mika Medical Company Information
  57. 8.10.2 Mika Medical Business Overview
  58. 8.10.3 Mika Medical Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mika Medical Insulin Needle-free Injection Pen Product Portfolio
  60. 8.10.5 Mika Medical Recent Developments
  61. 8.11 Lepu Medical Technology (Beijing) Co., Ltd.
  62. 8.11.1 Lepu Medical Technology (Beijing) Co., Ltd. Company Information
  63. 8.11.2 Lepu Medical Technology (Beijing) Co., Ltd. Business Overview
  64. 8.11.3 Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Product Portfolio
  66. 8.11.5 Lepu Medical Technology (Beijing) Co., Ltd. Recent Developments
  67. 8.12 Shandong Zhongbaokang Medical Equipment Co.,Ltd
  68. 8.12.1 Shandong Zhongbaokang Medical Equipment Co.,Ltd Company Information
  69. 8.12.2 Shandong Zhongbaokang Medical Equipment Co.,Ltd Business Overview
  70. 8.12.3 Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Product Portfolio
  72. 8.12.5 Shandong Zhongbaokang Medical Equipment Co.,Ltd Recent Developments
  73. 8.13 Jiangxi Sanxin Medtec Co.,Ltd.
  74. 8.13.1 Jiangxi Sanxin Medtec Co.,Ltd. Company Information
  75. 8.13.2 Jiangxi Sanxin Medtec Co.,Ltd. Business Overview
  76. 8.13.3 Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio
  78. 8.13.5 Jiangxi Sanxin Medtec Co.,Ltd. Recent Developments
  79. 8.14 Quinovare
  80. 8.14.1 Quinovare Company Information
  81. 8.14.2 Quinovare Business Overview
  82. 8.14.3 Quinovare Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Quinovare Insulin Needle-free Injection Pen Product Portfolio
  84. 8.14.5 Quinovare Recent Developments
  85. 8.15 Joyomed Suzhou Co.,Ltd.
  86. 8.15.1 Joyomed Suzhou Co.,Ltd. Company Information
  87. 8.15.2 Joyomed Suzhou Co.,Ltd. Business Overview
  88. 8.15.3 Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio
  90. 8.15.5 Joyomed Suzhou Co.,Ltd. Recent Developments
  91. 8.16 Sinocare
  92. 8.16.1 Sinocare Company Information
  93. 8.16.2 Sinocare Business Overview
  94. 8.16.3 Sinocare Insulin Needle-free Injection Pen Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sinocare Insulin Needle-free Injection Pen Product Portfolio
  96. 8.16.5 Sinocare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insulin Needle-free Injection Pen Value Chain Analysis
  2. 9.1.1 Insulin Needle-free Injection Pen Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insulin Needle-free Injection Pen Production Mode & Process
  6. 9.2 Insulin Needle-free Injection Pen Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insulin Needle-free Injection Pen Distributors
  9. 9.2.3 Insulin Needle-free Injection Pen Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst